
Mizuho Medy Co Ltd
TSE:4595

Mizuho Medy Co Ltd
Accounts Receivables
Mizuho Medy Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mizuho Medy Co Ltd
TSE:4595
|
Accounts Receivables
ÂĄ4.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
![]() |
Terumo Corp
TSE:4543
|
Accounts Receivables
ÂĄ186B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
![]() |
Olympus Corp
TSE:7733
|
Accounts Receivables
ÂĄ188.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
![]() |
Sysmex Corp
TSE:6869
|
Accounts Receivables
ÂĄ152.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
![]() |
Nihon Kohden Corp
TSE:6849
|
Accounts Receivables
ÂĄ62B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
![]() |
JEOL Ltd
TSE:6951
|
Accounts Receivables
ÂĄ45.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

See Also
What is Mizuho Medy Co Ltd's Accounts Receivables?
Accounts Receivables
4.5B
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Accounts Receivables amounts to 4.5B JPY.
What is Mizuho Medy Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
13%
Over the last year, the Accounts Receivables growth was 3%. The average annual Accounts Receivables growth rates for Mizuho Medy Co Ltd have been 4% over the past three years , 13% over the past five years .